Biotechnology Assets S.A. (BST) — Free Cash Flow Generation Index

Latest as of June 2025: 1.00x

Biotechnology Assets S.A. (BST) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of €656.15K represents 1% of operating cash flow (€658.13K). See Biotechnology Assets S.A. (BST) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

€656.15K
EUR

Operating Cash Flow

€658.13K
EUR

Capital Expenditures

€1.99K
EUR

Biotechnology Assets S.A. Free Cash Flow Generation Index (2015–2023)

Historical FCF Generation Index trend for Biotechnology Assets S.A. across 5 annual periods. Explore BST cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Biotechnology Assets S.A. (2015–2023)

Year-by-year Free Cash Flow Generation Index for Biotechnology Assets S.A.. For the full company profile including market capitalisation, see market value of Biotechnology Assets S.A..

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2023 -5.83x €-278.23K €47.74K €325.97K ▼ -710.0%
2020 0.96x €8.40 Million €8.79 Million €391.53K ▲ +115.1%
2017 -6.33x €-1.35 Million €213.49K €1.56 Million ▼ -2994.9%
2016 -0.20x €-555.22K €2.71 Million €3.27 Million ▲ +96.4%
2015 -5.75x €-910.02K €158.16K €1.07 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).